Artículos de revistas sobre el tema "Clot structure"
Crea una cita precisa en los estilos APA, MLA, Chicago, Harvard y otros
Consulte los 50 mejores artículos de revistas para su investigación sobre el tema "Clot structure".
Junto a cada fuente en la lista de referencias hay un botón "Agregar a la bibliografía". Pulsa este botón, y generaremos automáticamente la referencia bibliográfica para la obra elegida en el estilo de cita que necesites: APA, MLA, Harvard, Vancouver, Chicago, etc.
También puede descargar el texto completo de la publicación académica en formato pdf y leer en línea su resumen siempre que esté disponible en los metadatos.
Explore artículos de revistas sobre una amplia variedad de disciplinas y organice su bibliografía correctamente.
Smith, Stephanie A. y James H. Morrissey. "Polyphosphate Enhances Fibrin Clot Structure." Blood 110, n.º 11 (16 de noviembre de 2007): 403. http://dx.doi.org/10.1182/blood.v110.11.403.403.
Texto completoMihalko, Emily y Ashley C. Brown. "Clot Structure and Implications for Bleeding and Thrombosis". Seminars in Thrombosis and Hemostasis 46, n.º 01 (15 de octubre de 2019): 096–104. http://dx.doi.org/10.1055/s-0039-1696944.
Texto completoWolberg, Alisa S., Dougald M. Monroe, Harold R. Roberts y Maureane Hoffman. "Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk". Blood 101, n.º 8 (15 de abril de 2003): 3008–13. http://dx.doi.org/10.1182/blood-2002-08-2527.
Texto completoSmith, Stephanie A. y James H. Morrissey. "Polyphosphate enhances fibrin clot structure". Blood 112, n.º 7 (1 de octubre de 2008): 2810–16. http://dx.doi.org/10.1182/blood-2008-03-145755.
Texto completoCelińska-Löwenhoff, Magdalena, Teresa Iwaniec, Agnieszka Padjas, Jacek Musiał y Anetta Undas. "Altered fibrin clot structure/function in patients with antiphospholipid syndrome: association with thrombotic manifestation". Thrombosis and Haemostasis 112, n.º 08 (2014): 287–96. http://dx.doi.org/10.1160/th13-11-0980.
Texto completoCarr, M. E. y S. L. Zekert. "Abnormal clot retraction, altered fibrin structure, and normal platelet function in multiple myeloma". American Journal of Physiology-Heart and Circulatory Physiology 266, n.º 3 (1 de marzo de 1994): H1195—H1201. http://dx.doi.org/10.1152/ajpheart.1994.266.3.h1195.
Texto completoGersh, Kathryn, Chandrasekaran Nagaswami y John Weisel. "Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes". Thrombosis and Haemostasis 102, n.º 12 (2009): 1169–75. http://dx.doi.org/10.1160/th09-03-0199.
Texto completoHenderson, Sara J., Jing Xia, Huayin Wu, Alan R. Stafford, Beverly A. Leslie, James C. Fredenburgh, David A. Weitz y Jeffrey I. Weitz. "Zinc promotes clot stability by accelerating clot formation and modifying fibrin structure". Thrombosis and Haemostasis 115, n.º 03 (2016): 533–42. http://dx.doi.org/10.1160/th15-06-0462.
Texto completoMartinez, Marissa R., Adam Cuker, Angela M. Mills, Amanda Crichlow, Richard T. Lightfoot, Irina N. Chernysh, Chandrasekaran Nagaswami, John W. Weisel y Harry Ischiropoulos. "Enhanced lysis and accelerated establishment of viscoelastic properties of fibrin clots are associated with pulmonary embolism". American Journal of Physiology-Lung Cellular and Molecular Physiology 306, n.º 5 (1 de marzo de 2014): L397—L404. http://dx.doi.org/10.1152/ajplung.00265.2013.
Texto completoJanmey, PA, JA Lamb, RM Ezzell, S. Hvidt y SE Lind. "Effects of actin filaments on fibrin clot structure and lysis". Blood 80, n.º 4 (15 de agosto de 1992): 928–36. http://dx.doi.org/10.1182/blood.v80.4.928.928.
Texto completoJanmey, PA, JA Lamb, RM Ezzell, S. Hvidt y SE Lind. "Effects of actin filaments on fibrin clot structure and lysis". Blood 80, n.º 4 (15 de agosto de 1992): 928–36. http://dx.doi.org/10.1182/blood.v80.4.928.bloodjournal804928.
Texto completoVarin, Remi, Shasultan Mirshahi, Pehzman Mirshahi, Li Lu-Hong, Gerald Kierzek, Jean-Francois Vigneau, Jean-Pierre Marie et al. "Improvement of Thrombolysis by Rivaroxaban, An Anti Xa Inhibitor. Potential Therapeutic Importance in Patients with Thrombosis". Blood 112, n.º 11 (16 de noviembre de 2008): 3031. http://dx.doi.org/10.1182/blood.v112.11.3031.3031.
Texto completoFaes, Camille, Anton Ilich, Erica M. Sparkenbaugh, Alisa S. Wolberg, Brian C. Cooley, Kenneth I. Ataga, Nigel S. Key y Rafal Pawlinski. "Alteration of the Structure and Dynamics of Venous Clot Formation in Human and Murine Sickle Cell Disease". Blood 128, n.º 22 (2 de diciembre de 2016): 2478. http://dx.doi.org/10.1182/blood.v128.22.2478.2478.
Texto completoBrown, Ashley C., Riley H. Hannan, Lucas H. Timmins, Janet D. Fernandez, Thomas H. Barker y Nina A. Guzzetta. "Fibrin Network Changes in Neonates after Cardiopulmonary Bypass". Anesthesiology 124, n.º 5 (1 de mayo de 2016): 1021–31. http://dx.doi.org/10.1097/aln.0000000000001058.
Texto completoGao, Chunli, Bin Bao, Chunling Bao y Wenhui Wu. "Fungi Fibrinolytic Compound 1 Plays a Core Role in Modulating Fibrinolysis, Altering Plasma Clot Structure, and Promoting Susceptibility to Lysis". Pharmaceutics 15, n.º 9 (14 de septiembre de 2023): 2320. http://dx.doi.org/10.3390/pharmaceutics15092320.
Texto completoHantgan, Roy R., W. Gray Jerome y Marcie J. Hursting. "No Effect of Clot Age or Thrombolysis on Argatroban’s Inhibition of Thrombin". Blood 92, n.º 6 (15 de septiembre de 1998): 2064–74. http://dx.doi.org/10.1182/blood.v92.6.2064.
Texto completoHantgan, Roy R., W. Gray Jerome y Marcie J. Hursting. "No Effect of Clot Age or Thrombolysis on Argatroban’s Inhibition of Thrombin". Blood 92, n.º 6 (15 de septiembre de 1998): 2064–74. http://dx.doi.org/10.1182/blood.v92.6.2064.418k07_2064_2074.
Texto completoBaradet, T., J. W. Weisel y L. D. Peachey. "A study of fibrin clot structure under various ionic conditions using stereoscopic IVEM images". Proceedings, annual meeting, Electron Microscopy Society of America 49 (agosto de 1991): 194–95. http://dx.doi.org/10.1017/s0424820100085277.
Texto completoFlood, Veronica H., Chandrasekaran Nagaswami, Irina N. Chernysh, Hamid A. Al-Mondhiry, John W. Weisel y David H. Farrell. "Effects of Impaired Fibrinopeptide A Cleavage on Fibrin Clot Structure: Studies with an Aα R16C Dysfibrinogen." Blood 108, n.º 11 (16 de noviembre de 2006): 1617. http://dx.doi.org/10.1182/blood.v108.11.1617.1617.
Texto completoJerome, W. Gray, Stefan Handt y Roy R. Hantgan. "Endothelial Cells Organize Fibrin Clots into Structures That Are More Resistant to Lysis". Microscopy and Microanalysis 11, n.º 3 (12 de mayo de 2005): 268–77. http://dx.doi.org/10.1017/s143192760505052x.
Texto completoChernysh, Irina N., Prashant K. Purohit, Chandrasekaran Nagaswami y John W. Weisel. "Remodeling of Clots without Proteolytic Digestion". Blood 118, n.º 21 (18 de noviembre de 2011): 1184. http://dx.doi.org/10.1182/blood.v118.21.1184.1184.
Texto completoGreenhalgh, Katie A., Mark W. Strachan, Saad Alzahrani, Paul D. Baxter, Kristina F. Standeven, Robert F. Storey, Robert A. S. Ariens, Peter J. Grant, Jackie F. Price y Ramzi A. Ajjan. "BβArg448Lys polymorphism is associated with altered fibrin clot structure and fibrinolysis in type 2 diabetes". Thrombosis and Haemostasis 117, n.º 02 (2017): 295–302. http://dx.doi.org/10.1160/th16-07-0554.
Texto completoKonings, Joke, José W. P. Govers-Riemslag, Helen Philippou, Nicola J. Mutch, Julian I. Borissoff, Peter Allan, Sumitra Mohan, Guido Tans, Hugo ten Cate y Robert A. S. Ariëns. "Factor XIIa regulates the structure of the fibrin clot independently of thrombin generation through direct interaction with fibrin". Blood 118, n.º 14 (6 de octubre de 2011): 3942–51. http://dx.doi.org/10.1182/blood-2011-03-339572.
Texto completode Vries, Judith J., Tamara Hoppenbrouwers, Cristina Martinez-Torres, Rezin Majied, Behiye Özcan, Mandy van Hoek, Frank W. G. Leebeek, Dingeman C. Rijken, Gijsje H. Koenderink y Moniek P. M. de Maat. "Effects of Diabetes Mellitus on Fibrin Clot Structure and Mechanics in a Model of Acute Neutrophil Extracellular Traps (NETs) Formation". International Journal of Molecular Sciences 21, n.º 19 (26 de septiembre de 2020): 7107. http://dx.doi.org/10.3390/ijms21197107.
Texto completoDe Vries, Judith Juliana, Chantal Visser, Lotte Geers, Johan A. Slotman, Henrik Endeman, Marieke J. H. A. Kruip, Moniek P. M. de Maat y The Dutch COVID & Thrombosis Coalition. "Does Fibrin Structure Contribute to the Increased Risk of Thrombosis in COVID-19 ICU Patients?" Blood 138, Supplement 1 (5 de noviembre de 2021): 3208. http://dx.doi.org/10.1182/blood-2021-145307.
Texto completoXu, Shixin, Zhiliang Xu, Oleg V. Kim, Rustem I. Litvinov, John W. Weisel y Mark Alber. "Model predictions of deformation, embolization and permeability of partially obstructive blood clots under variable shear flow". Journal of The Royal Society Interface 14, n.º 136 (noviembre de 2017): 20170441. http://dx.doi.org/10.1098/rsif.2017.0441.
Texto completoNeergaard-Petersen, Søs, Anne-Mette Hvas, Steen Kristensen, Erik Grove, Sanne Larsen, Fladia Phoenix, Zeyad Kurdee, Peter Grant y Ramzi Ajjan. "The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease". Thrombosis and Haemostasis 112, n.º 12 (2014): 1142–50. http://dx.doi.org/10.1160/th14-05-0468.
Texto completoJen, C. J. y L. V. McIntire. "Platelet Microtubules in Clot Structure Formation and Contractile Force Generation: Investigation of a Controversy". Thrombosis and Haemostasis 56, n.º 01 (1986): 023–27. http://dx.doi.org/10.1055/s-0038-1661596.
Texto completoLeong, Lilley, Irina N. Chernysh, Yifan Xu, Cornell Mallari, Billy Wong, Derek Sim, Adam Cuker et al. "Hemophilia a Clots Generated with Recombinant Factor VIIa Differed in Structure and Composition from Those Formed with Factor VIII". Blood 128, n.º 22 (2 de diciembre de 2016): 3798. http://dx.doi.org/10.1182/blood.v128.22.3798.3798.
Texto completoTutwiler, Valerie, Alina D. Peshkova, Giang Le Minh, Sergei Zaitsev, Rustem I. Litvinov, Douglas B. Cines y John W. Weisel. "Fibrinolysis of Contracted Blood Clots Depends on Whether Plasminogen Activator Acts from inside or Outside". Blood 132, Supplement 1 (29 de noviembre de 2018): 3773. http://dx.doi.org/10.1182/blood-2018-99-119659.
Texto completoWhyte, Claire S., Akriti Rastogi, Ellis Ferguson, Michela Donnarumma y Nicola J. Mutch. "The Efficacy of Fibrinogen Concentrates in Relation to Cryoprecipitate in Restoring Clot Integrity and Stability against Lysis". International Journal of Molecular Sciences 23, n.º 6 (9 de marzo de 2022): 2944. http://dx.doi.org/10.3390/ijms23062944.
Texto completoUndas, Anetta, Krystyna Zawilska, Mariola Ciesla-Dul, Agata Lehmann-Kopydłowska, Agnieszka Skubiszak, Katarzyna Ciepłuch y Wiesława Tracz. "Altered fibrin clot structure/function in patients with idiopathic venous thromboembolism and in their relatives". Blood 114, n.º 19 (5 de noviembre de 2009): 4272–78. http://dx.doi.org/10.1182/blood-2009-05-222380.
Texto completoSidelmann, Johannes, Mikkel Brabrand, Robert Pedersen, Jørgen Pedersen, Kim Esbensen, Kristina Standeven, Robert Ariëns, Jørgen Gram y Jonas Sjøland. "Fibrin clot structure in patients with end-stage renal disease". Thrombosis and Haemostasis 98, n.º 08 (2007): 339–45. http://dx.doi.org/10.1160/th06-12-0715.
Texto completoDavies, Nia Anne, Nicholas Kim Harrison, Roger H. Keith Morris, Simon Noble, Matthew James Lawrence, Lindsay Antonio D’Silva, Laura Broome et al. "Fractal dimension (df ) as a new structural biomarker of clot microstructure in different stages of lung cancer". Thrombosis and Haemostasis 114, n.º 12 (2015): 1251–59. http://dx.doi.org/10.1160/th15-04-0357.
Texto completode Vries, Judith J., Charlotte J. M. Snoek, Dingeman C. Rijken y Moniek P. M. de Maat. "Effects of Post-Translational Modifications of Fibrinogen on Clot Formation, Clot Structure, and Fibrinolysis". Arteriosclerosis, Thrombosis, and Vascular Biology 40, n.º 3 (marzo de 2020): 554–69. http://dx.doi.org/10.1161/atvbaha.119.313626.
Texto completoGaule, Thembaninkosi G. y Ramzi A. Ajjan. "Fibrin(ogen) as a Therapeutic Target: Opportunities and Challenges". International Journal of Molecular Sciences 22, n.º 13 (28 de junio de 2021): 6916. http://dx.doi.org/10.3390/ijms22136916.
Texto completoWeisel, John W. "Multiple Approaches to Visualizing Fibrin Clot Structure and Assembly". Microscopy and Microanalysis 3, S2 (agosto de 1997): 329–30. http://dx.doi.org/10.1017/s1431927600008539.
Texto completoGantioqui, Jorell, Ivan Stevic, Paul Y. Kim, Keith K. Lau, Anthony K. C. Chan y Howard H. W. Chan. "The Architecture Of Fibrin Clots Formed From Plasma With Low Platelet Levels Are Less Altered In The Presence Of Factor-Specific Anticoagulants Compared With Unfractionated Heparin". Blood 122, n.º 21 (15 de noviembre de 2013): 578. http://dx.doi.org/10.1182/blood.v122.21.578.578.
Texto completoFaes, Camille, Anton Ilich, Amandine Sotiaux, Erica M. Sparkenbaugh, Michael W. Henderson, Laura Buczek, Joan D. Beckman et al. "Red blood cells modulate structure and dynamics of venous clot formation in sickle cell disease". Blood 133, n.º 23 (6 de junio de 2019): 2529–41. http://dx.doi.org/10.1182/blood.2019000424.
Texto completoVarin, Remi, Shahsultan Mirshahi, Pehzman Mirshahi, Jean Chidiac, Gerald Kierzek, Jean-Pierre Marie, Massoud Mirshahi, Claudine Soria y Jeannette Soria. "Effect of Rivaroxaban, An Oral Direct Factor Xa Inhibitor, On Whole Blood Clot Permeation and Thrombolysis: Critical Role of Red Blood Cells." Blood 114, n.º 22 (20 de noviembre de 2009): 1064. http://dx.doi.org/10.1182/blood.v114.22.1064.1064.
Texto completoUndas, Anetta. "Fibrin clot properties and their modulation in thrombotic disorders". Thrombosis and Haemostasis 112, n.º 07 (2014): 32–42. http://dx.doi.org/10.1160/th14-01-0032.
Texto completoDargaud, Yesim, Jean C. Bordet, Chantal Huchon y Claude Negrier. "How can We Predict Efficacy of rFVIIa in Hemophilia Patients with Inhibitors?" Blood 114, n.º 22 (20 de noviembre de 2009): 3487. http://dx.doi.org/10.1182/blood.v114.22.3487.3487.
Texto completoWeisel, John W., Tatiana Lebedeva, Chandrasekaran Nagaswami, Vincent M. Hayes, Walter Massefski, Rustem I. Litvinov, Lubica Rauova, Thomas J. Lowery y Douglas B. Cines. "Polyhedrocytes: Compressed Polyhedral Erythrocytes In Contracted Blood Clots and Thrombi". Blood 122, n.º 21 (15 de noviembre de 2013): 452. http://dx.doi.org/10.1182/blood.v122.21.452.452.
Texto completoAjjan, Ramzi, Bernard C. B. Lim, Kristina F. Standeven, Robert Harrand, Sarah Dolling, Fladia Phoenix, Richard Greaves et al. "Common variation in the C-terminal region of the fibrinogen β-chain: effects on fibrin structure, fibrinolysis and clot rigidity". Blood 111, n.º 2 (15 de enero de 2008): 643–50. http://dx.doi.org/10.1182/blood-2007-05-091231.
Texto completoLandi, Elia, Marco Mugnaini, Tunahan Vatansever, Ada Fort, Valerio Vignoli, Elvira Giurranna, Flavia Rita Argento et al. "Advancing Thrombosis Research: A Novel Device for Measuring Clot Permeability". Sensors 24, n.º 12 (9 de junio de 2024): 3764. http://dx.doi.org/10.3390/s24123764.
Texto completoZąbczyk, Michał, Joanna Natorska y Anetta Undas. "Factor XIII and Fibrin Clot Properties in Acute Venous Thromboembolism". International Journal of Molecular Sciences 22, n.º 4 (5 de febrero de 2021): 1607. http://dx.doi.org/10.3390/ijms22041607.
Texto completoBowley, Sheryl R. y Susan T. Lord. "Fibrinogen variant BβD432A has normal polymerization but does not bind knob “B”". Blood 113, n.º 18 (30 de abril de 2009): 4425–30. http://dx.doi.org/10.1182/blood-2008-09-178178.
Texto completoPan, Xiaoxi, Yun Gong, Ya Xu, Robert Ariens y Michael Routledge. "Urban Particulate Matter Induces Changes in Gene Expression in Vascular Endothelial Cells that Are Associated with Altered Clot Structure In Vitro". Thrombosis and Haemostasis 118, n.º 02 (2018): 266–78. http://dx.doi.org/10.1160/th17-05-0362.
Texto completoMoiseiwitsch, Nina, Kimberly A. Nellenbach, Nina A. Guzzetta, Ashley C. Brown y Laura Downey. "Ex Vivo and In Vivo Evaluation of Fibrinogen Concentrate to Mitigate Post-Surgical Bleeding in Neonates". Blood 138, Supplement 1 (5 de noviembre de 2021): 1034. http://dx.doi.org/10.1182/blood-2021-153823.
Texto completoCollet, Jean-Philippe, Jennifer L. Moen, Yuri I. Veklich, Oleg V. Gorkun, Susan T. Lord, Gilles Montalescot y John W. Weisel. "The αC domains of fibrinogen affect the structure of the fibrin clot, its physical properties, and its susceptibility to fibrinolysis". Blood 106, n.º 12 (1 de diciembre de 2005): 3824–30. http://dx.doi.org/10.1182/blood-2005-05-2150.
Texto completo